Sales rise 11.18% to Rs 819.22 crore
Net Loss of Jubilant Life Sciences reported to Rs 105.88 crore in the quarter ended June 2013 as against net loss of Rs 73.60 crore during the previous quarter ended June 2012. Sales rose 11.18% to Rs 819.22 crore in the quarter ended June 2013 as against Rs 736.82 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales819.22736.82 11 OPM %13.4416.36 -PBDT63.9477.20 -17 PBT21.4041.13 -48 NP-105.88-73.60 -44Powered by Capital Market - Live News